304 related articles for article (PubMed ID: 3426951)
1. Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of lupus erythematosus.
Błaszczyk M; Majewski S; Wasik M; Chorzelski T; Jabłonska S
Br J Dermatol; 1987 Dec; 117(6):709-14. PubMed ID: 3426951
[TBL] [Abstract][Full Text] [Related]
2. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.
Hofmann SC; Bosma A; Bruckner-Tuderman L; Vukmanovic-Stejic M; Jury EC; Isenberg DA; Mauri C
J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188
[TBL] [Abstract][Full Text] [Related]
3. Distribution of natural killer cells and lymphocyte subclasses in Jessner's lymphocytic infiltration of the skin and in cutaneous lesions of discoid and systemic lupus erythematosus.
Viljaranta S; Ranki A; Kariniemi AL; Nieminen P; Johansson L
Br J Dermatol; 1987 Jun; 116(6):831-8. PubMed ID: 3497663
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.
Gu HJ; Song S; Roh JY; Jung Y; Kim HJ
Lupus; 2021 Aug; 30(9):1427-1437. PubMed ID: 34013817
[TBL] [Abstract][Full Text] [Related]
5. Direct immunofluorescence in lupus erythematosus (LE).
Isfer RS; Sanches Júnior JA; Festa Neto C; Cernea SS; de Oliveira ZN; Vilela MA; Silva ML; Miyachi LM; Fukumori LM; da Silva SR
Sao Paulo Med J; 1996; 114(2):1141-7. PubMed ID: 9077025
[TBL] [Abstract][Full Text] [Related]
6. Anti C1q antibodies in cutaneous lupus erythematosus.
Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in patients with Lupus erythematosus: spectrum and frequencies.
Wenzel J; Bauer R; Bieber T; Böhm I
Dermatology; 2000; 201(3):282-3. PubMed ID: 11096213
[No Abstract] [Full Text] [Related]
8. Selective expansions of T cells expressing V beta 8 and V beta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus.
Furukawa F; Tokura Y; Matsushita K; Iwasaki-Inuzuka K; Onagi-Suzuki K; Yagi H; Wakita H; Takigawa M
J Dermatol; 1996 Oct; 23(10):670-6. PubMed ID: 8973031
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing subacute cutaneous from other types of lupus erythematosus.
McCauliffe DP
Lancet; 1998 May; 351(9115):1527-8. PubMed ID: 10326532
[No Abstract] [Full Text] [Related]
10. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological characteristics of patients with cutaneous lupus erythematosus.
Avilés Izquierdo JA; Cano Martínez N; Lázaro Ochaita P
Actas Dermosifiliogr; 2014; 105(1):69-73. PubMed ID: 24268922
[TBL] [Abstract][Full Text] [Related]
13. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
14. [Detection of circulating antibodies in the blood and immune complex precipitates of patients with autoimmune diseases (preliminary report)].
Kiss M; Husz S; Dobozy A
Orv Hetil; 1992 May; 133(18):1103-4, 1109-10. PubMed ID: 1579350
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous lupus erythematosus in India: immunofluorescence profile.
George R; Mathai R; Kurian S
Int J Dermatol; 1992 Apr; 31(4):265-9. PubMed ID: 1634292
[TBL] [Abstract][Full Text] [Related]
16. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
Tebbe B; Orfanos CE
Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
[TBL] [Abstract][Full Text] [Related]
17. Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function.
Konstadoulakis MM; Kroubouzos G; Tosca A; Piperingos G; Marafelia P; Konstadoulakis M; Varelzidis A; Koutras DA
Thyroidology; 1993 Apr; 5(1):1-7. PubMed ID: 7508737
[TBL] [Abstract][Full Text] [Related]
18. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.
Sibbitt WL; Mathews PM; Bankhurst AD
Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394
[TBL] [Abstract][Full Text] [Related]
19. [Lupus erythematosus].
Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Astragalus membranaceus and Tripterygium hypoglancum on natural killer cell activity of peripheral blood mononuclear in systemic lupus erythematosus].
Zhao XZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Nov; 12(11):669-71, 645. PubMed ID: 1301849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
